Axa’s HI-TECH PHARMACAL INC HITK Stock Holding History

Axa’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-600	Closed	-$20K	–	1382
2013 Q2	$20K	Buy	+600	New	+$20K	﹤0.01%	1214

Other funds holding HITK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Axa's HITK Position: Q3 2013 in Review

Axa sold out of HI-TECH PHARMACAL INC (HITK) in Q3 2013, closing a stake of 600 shares — an estimated $20K sold.

Axa first reported a position in HITK in Q2 2013 and held it in 1 quarter. The position peaked at $20K in Q2 2013. 105 funds tracked by Wall St. Rank hold HITK as of Q3 2013.

Axa reported no remaining HI-TECH PHARMACAL INC position as of Q3 2013 after selling out during the quarter.
Axa sold 600 HI-TECH PHARMACAL INC shares in Q3 2013, an estimated $20K.
Axa first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 1 quarter.
Axa's HI-TECH PHARMACAL INC position peaked at $20K in Q2 2013.
105 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q3 2013.

Based on Axa's 13F filing for Q3 2013, filed 13 Nov 2013.